Medical evaluation and treatment of urolithiasis

Pediatr Clin North Am. 2006 Jun;53(3):479-91, vii. doi: 10.1016/j.pcl.2006.03.001.

Abstract

Nephrolithiasis is responsible for 1 in 1000 to 1 in 7600 pediatric hospital admissions annually throughout the United States. Seventy-five percent of children with nephrolithiasis have an identifiable predisposition to stone formation. This article reviews the different causes and disease states associated with nephrolithiasis in the pediatric population. The initial evaluation and the metabolic evaluation of children with nephrolithiasis are reviewed. Treatment modalities for the different stone types are also described.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Adolescent
  • Calcium Metabolism Disorders / complications
  • Calcium Metabolism Disorders / diagnosis
  • Calcium Metabolism Disorders / therapy
  • Calcium Metabolism Disorders / urine
  • Child
  • Child, Preschool
  • Cystinuria / complications
  • Cystinuria / diagnosis
  • Cystinuria / therapy
  • Cystinuria / urine
  • Humans
  • Hyperoxaluria / complications
  • Hyperoxaluria / diagnosis
  • Hyperoxaluria / therapy
  • Hyperoxaluria / urine
  • Infant
  • Infant, Newborn
  • Metabolic Diseases / complications
  • Metabolic Diseases / diagnosis
  • Metabolic Diseases / therapy
  • Metabolic Diseases / urine
  • Uric Acid / urine
  • Urinalysis / methods
  • Urinary Calculi / diagnosis*
  • Urinary Calculi / etiology
  • Urinary Calculi / therapy*

Substances

  • Uric Acid